肥満治療の世界市場分析:薬別(配合剤、食欲抑制、吸収不良・満腹薬)、手術・装置別(調整可能な胃バンド、ルーワイ胃バイパス術、スリーブ状胃切除術、十二指腸切開胆管胆道摘出術、内視鏡手術)、動向分析...市場調査レポートについてご紹介

【英文タイトル】Obesity Treatment Market Size & Forecast, By Drugs (Combination Drugs, Appetite Suppressants, Malabsorption & Satiety Drugs), By Surgery & Devices (Adjustable Gastric Banding, Roux-en-Y Gastric Bypass, Sleeve Gastrectomy, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures) And Trend Analysis To 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
4.1 Market Segmentation & Scope
4.1.1 Market Driver Analysis
4.1.1.1. Growing global prevalence of obesity
4.1.1.2. Changing lifestyles and food habits
4.1.1.3. Demand for minimally invasive procedures
4.1.1.4. Rising awareness about the different bariatric surgeries
4.1.2 Market Restraint Analysis
4.1.2.1.Complexities related to obesity treatment
4.1.2.2.High cost associated to surgeries
4.1.2.3. Limited insurance coverage
4.2 Obesity Treatment Market – SWOT Analysis
4.3 Industry Analysis – Porter’s
Chapter 5 Market Categorization 1: Product Estimates & Trend Analysis
5.1.Obesity Treatment Market: Product Movement Analysis
5.1.1. Combination drugs
5.1.2. Appetite supressants
5.1.3. Malabsorption
5.1.4. Satiety
Chapter 6 Market Categorization 2: Surgery & Devices Estimates & Trend Analysis
6.1. Obesity Treatment Market: Surgery & Devices Movement Analysis
6.1.1. Adjustable gastric banding
6.1.2. Roux-en-Y gastric bypass
6.1.3. Sleeve gastrectomy
6.1.4. Billiopancreatic diversion with duodenal switch
6.1.5. Endoscopic procedures
6.1.6. Others
Chapter 7 Market Categorization 2: Regional Estimates & Trend Analysis, by Product
7.1. North America
7.1.1. U.S.
7.1.2.Canada
7.2. Europe
7.2.1UK
7.2.2. Germany
7.2.3 Asia Pacific
7.2.3.1 Japan
7.2.3.2 China
7.2.4 Latin America
7.2.4.1 Brazil
7.2.4.2 Mexico
7.2.5 MEA
7.2.5.1 South Africa
Chapter 8 Competitive Landscape
8.1 Strategy framework
8.2 Market participation categorization
8.3 Company Profiles
8.3.1 VIVUS, Inc.
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 Arena Pharmaceuticals, Inc.
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 F. Hoffmann-La Roche, Ltd.
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 Novo Nordisk A/S
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Orexigen Therapeutics, Inc.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Allergan
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 Cousin Biotech
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 EnteroMedics, Inc.
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Ethicon ( Subsidiary of Johnson & Johnson)
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Medtronic
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 USGI Medical, Inc.
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives
8.3.12 Mediflex Surgical Products
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic initiatives


【レポート販売概要】

■ タイトル:肥満治療の世界市場分析:薬別(配合剤、食欲抑制、吸収不良・満腹薬)、手術・装置別(調整可能な胃バンド、ルーワイ胃バイパス術、スリーブ状胃切除術、十二指腸切開胆管胆道摘出術、内視鏡手術)、動向分析
■ 英文:Obesity Treatment Market Size & Forecast, By Drugs (Combination Drugs, Appetite Suppressants, Malabsorption & Satiety Drugs), By Surgery & Devices (Adjustable Gastric Banding, Roux-en-Y Gastric Bypass, Sleeve Gastrectomy, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures) And Trend Analysis To 2024
■ 発行日:2016年9月8日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707600
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。